Microbiology & Infectious Diseases

Filter

Timely Prevention of Adolescent Invasive Meningococcal Disease

December 2025

IMD is an uncommon and unpredictable disease with a high case fatality rate. Five to ten percent of patients with IMD die within the first…

Timely Prevention of Adolescent Invasive Meningococcal Disease

IMD is an uncommon and unpredictable disease with a high case fatality rate. Five to ten percent of patients with IMD die within the first…

Cohort Profile: The COVID-19 Ticino Biobank

When the COVID-19 pandemic reached Europe, little was known. It was mostly reported by the Chinese authorities, and therefore…

Long-Acting Injectables for HIV

Karine Lacombe, Professor at Sorbonne Université, Paris, France, set the scene by outlining the current trajectory of the HIV epidemic and…

Clinical Challenges in HIV

The HIV treatment landscape is evolving, ushering in the era of long-acting (LA) antiretroviral therapy (ART) to support the challenges…

Mycoplasma Pneumoniae-Induced Rash and Mucositis

A 24-year-old male with no history of immune deficiency, diabetes, or drug allergies presented to the emergency department. He experienced…

Pneumocystis Jirovecii Pneumonia in Patients Without HIV

Pneumocystis jirovecii pneumonia (PCP) is an opportunistic fungal infection commonly affecting immunocompromised patients, most notably…

Timely Prevention of Adolescent Invasive Meningococcal Disease

In August 2025, EMJ conducted individual interviews with two European medical experts and a patient advocate who…

Patient-Reported Outcome Measures, 1 Year After COVID-19

Learn more about the long-term health effects persisting one year after COVID-19 infection, including fatigue, breathlessness…

Loading posts...

1 2 3 … 13 Next »